Abstract
A systematic review and meta‐analysis comprising 19 studies has found no significant association between use of medications for attention‐deficit hyperactivity disorder (ADHD) and risk of cardiovascular disease. The findings could not rule out the possibility of a modest increase in risk of cardiac arrest or tachyarrhythmias, the investigators reported. Results were published online Nov. 23, 2022, in JAMA Network Open.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: The Brown University Psychopharmacology Update
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
